AI in Medical Imaging Diagnostics: IDTechEx Benchmarks 60+ Companies

BOSTON, July 29, 2020 /PRNewswire/ -- IDTechEx Research predicts that the market for image recognition AI in medical diagnostics will exceed $3 billion by 2030. This article considers the competitive landscape by disease area, company readiness levels by application, and the trends in focus areas.

Companies sit at different stages of readiness. Although multiple firms are already selling, this alone does not guarantee success. Companies are trying one or multiple of the following approaches to succeed:

    --  Towards wider applicability: Showing that the AI is applicable to a wide
        population set is increasingly critical. This improves outcomes and
        widens market applicability, but is difficult to implement. One needs to
        place a robust data acquisition and learning loop via partnerships and
        customer relationships at the heart of the product development. When
        successful, this will serve to erect moats around the business, acting
        as a large barrier to entry for newcomers.
    --  Evolving beyond simple abnormality identification towards super-human
        insights: Whilst there is a spread in what different algorithms are
        offering, most are positioned as decision support tools. As a minimum,
        they need to detect (recognize + localize) the anomaly of interest. The
        evolution is to provide explanations alongside the object detection.
        Some are even aiming to suggest treatment options. In short, the goal is
        to raise the AI complexity beyond object detection.
    --  Scale: Large scale means more access to data, which translates into an
        ever-widening performance gap against competitors in terms of algorithm
        accuracy, versatility, and applicability. Interestingly, the big
        software firms (Google and Microsoft) have a big program on these topics
        but are yet to take the plunge into this competitive landscape.
    --  Aggressive pricing: The pricing model right now is based on either a
        tiered subscription model or a pay per use. However, the amortized
        development costs and the installation fees resemble more like a fixed
        cost, whilst the supplier's computing costs vary with the scanning
        volume so some type of per-use model will prevail. In general, the trend
        will be towards ever more competitive pricing. This is likely to be
        leveraged as a tool by well-funded organizations to force out smaller
        poorly capitalized competitors.

IDTechEx's report provides a detailed analysis of over 50 and examines the company landscape from both a commercial and technical standpoint. In-depth insights into current and upcoming technologies as well as detailed market analysis are also provided.

For more information on this report, please visit www.IDTechEx.com/IRAI or for the full portfolio of research available from IDTechEx please visit www.IDTechEx.com/Research.

IDTechEx guides your strategic business decisions through its Research, Consultancy and Event products, helping you profit from emerging technologies. For more information on IDTechEx Research and Consultancy, contact research@IDTechEx.com or visit www.IDTechEx.com.

Media Contact:
Natalie Moreton
Digital Marketing Manager
press@IDTechEx.com
+44(0)1223 812300

View original content to download multimedia:http://www.prnewswire.com/news-releases/ai-in-medical-imaging-diagnostics-idtechex-benchmarks-60-companies-301102393.html

SOURCE IDTechEx